filmov
tv
Goodfellow Unit Webinar: Congestive heart failure with preserved ejection fraction
Показать описание
Cardiologist Dr Gerry Devlin discusses Treatment options for congestive heart failure with preserved ejection fraction.
About 50% of patients with congestive heart failure (CHF) have preserved ejection fraction.
CHF with preserved ejection fraction has had no effective therapy other than to have good control of CVD risk factors (BP, lipids and smoking). The SGLT2 inhibitors are the first treatment to improve outcomes and so are a game changer when it comes to treating this condition.
Dr Devlin will walk us through the issues of treatment with SGLT2 inhibitors and ways to make the cost cheaper for patients as they are currently unfunded for CHF (only diabetes).
Chapters:
00:00 Intro
01:07 Presentation (Gerry Devlin)
24:39 Audience Q&A
About 50% of patients with congestive heart failure (CHF) have preserved ejection fraction.
CHF with preserved ejection fraction has had no effective therapy other than to have good control of CVD risk factors (BP, lipids and smoking). The SGLT2 inhibitors are the first treatment to improve outcomes and so are a game changer when it comes to treating this condition.
Dr Devlin will walk us through the issues of treatment with SGLT2 inhibitors and ways to make the cost cheaper for patients as they are currently unfunded for CHF (only diabetes).
Chapters:
00:00 Intro
01:07 Presentation (Gerry Devlin)
24:39 Audience Q&A